Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inhaled hypertonic saline benefits cystic fibrosis patients

Jan. 27, 2006

Recent Vertex patent reports new agents for cystic fibrosis

Jan. 26, 2006

LAB CGRP, safe with no serious adverse events in phase I study

Jan. 26, 2006

Vertex and CFFT extend cystic fibrosis research collaboration

Jan. 24, 2006

Phase IIb program planned for long-acting beta2 agonist GSK-159797

Jan. 24, 2006

Recent GSK patent imparts novel agents for respiratory disorders

Jan. 17, 2006

Menarini's promising new low-dose candidate for bronchoconstriction

Jan. 12, 2006

European orphan drug status for denufosol tetrasodium in cystic fibrosis

Jan. 12, 2006

Theravance prepares and tests novel beta2-adrenoceptor agonists for asthma

Jan. 11, 2006

Aradigm seeks orphan drug designation for liposomal ciprofloxacin

Jan. 11, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...